tetano
Editor, Senior Moderator
Vaccines (Basel)
. 2021 Feb 18;9(2):172.
doi: 10.3390/vaccines9020172.
Vaccine Hesitancy among Italian Patients Recovered from COVID-19 Infection towards Influenza and Sars-Cov-2 Vaccination
Valentina Gerussi[SUP] 1 [/SUP], Maddalena Peghin[SUP] 1 [/SUP], Alvisa Palese[SUP] 2 [/SUP], Valentina Bressan[SUP] 2 [/SUP], Erica Visintini[SUP] 2 [/SUP], Giulia Bontempo[SUP] 1 [/SUP], Elena Graziano[SUP] 1 [/SUP], Maria De Martino[SUP] 3 [/SUP], Miriam Isola[SUP] 3 [/SUP], Carlo Tascini[SUP] 1 [/SUP]
Affiliations
Abstract
We aimed to assess the attitude towards influenza and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccinations among coronavirus disease 2019 (COVID-19) recovered patients. We performed a cross-sectional study consisting of a standardized telephone interview carried out between September and November 2020 targeting a cohort of adult in- and out-patients that had recovered from COVID-19 after the first wave (March-May 2020) at Udine Hospital (Italy). Overall, 599 people participated (320 female, median age 53 years) and most had experienced an acute COVID-19 with mild illness (409, 68.3%). The majority were hesitant or undecided towards influenza (327, 54.6%) and SARS-CoV-2 (353, 59.2%) vaccines. Older age, public work exposure, and previous 2019 flu shots were the main factors associated with a positive attitude toward both vaccinations (p < 0.05). Being hospitalized during the acute COVID-19 phase was associated with the willingness to get a flu shot (94/272, 34.5%) but not SARS-CoV-2 vaccine (70/244, 28.7%). Vaccine hesitancy is diffuse and multifactorial also among COVID-19 recovered.
Keywords: COVID-19; SARS-CoV-2; influenza; pandemic; vaccination; vaccine hesitancy.
. 2021 Feb 18;9(2):172.
doi: 10.3390/vaccines9020172.
Vaccine Hesitancy among Italian Patients Recovered from COVID-19 Infection towards Influenza and Sars-Cov-2 Vaccination
Valentina Gerussi[SUP] 1 [/SUP], Maddalena Peghin[SUP] 1 [/SUP], Alvisa Palese[SUP] 2 [/SUP], Valentina Bressan[SUP] 2 [/SUP], Erica Visintini[SUP] 2 [/SUP], Giulia Bontempo[SUP] 1 [/SUP], Elena Graziano[SUP] 1 [/SUP], Maria De Martino[SUP] 3 [/SUP], Miriam Isola[SUP] 3 [/SUP], Carlo Tascini[SUP] 1 [/SUP]
Affiliations
- PMID: 33670661
- DOI: 10.3390/vaccines9020172
Abstract
We aimed to assess the attitude towards influenza and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccinations among coronavirus disease 2019 (COVID-19) recovered patients. We performed a cross-sectional study consisting of a standardized telephone interview carried out between September and November 2020 targeting a cohort of adult in- and out-patients that had recovered from COVID-19 after the first wave (March-May 2020) at Udine Hospital (Italy). Overall, 599 people participated (320 female, median age 53 years) and most had experienced an acute COVID-19 with mild illness (409, 68.3%). The majority were hesitant or undecided towards influenza (327, 54.6%) and SARS-CoV-2 (353, 59.2%) vaccines. Older age, public work exposure, and previous 2019 flu shots were the main factors associated with a positive attitude toward both vaccinations (p < 0.05). Being hospitalized during the acute COVID-19 phase was associated with the willingness to get a flu shot (94/272, 34.5%) but not SARS-CoV-2 vaccine (70/244, 28.7%). Vaccine hesitancy is diffuse and multifactorial also among COVID-19 recovered.
Keywords: COVID-19; SARS-CoV-2; influenza; pandemic; vaccination; vaccine hesitancy.